Position in ANNX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,520,150
+$405,669 QoQ
Shares Held
616,489
+9.7% QoQ
Ownership
0.302%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 216 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. ANNX ranks #81 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in ANNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,520,150 | 616,489 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $3,114,481 | 562,181 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $2,814,934 | 560,744 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,588,263 | 1,504,349 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,227,475 | 511,448 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,036,977 | 537,294 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $2,752,260 | 536,503 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $3,007,685 | 508,055 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $2,428,881 | 495,690 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $1,117,681 | 155,883 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $712,789 | 157,002 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $446,378 | 126,812 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $488,226 | 126,812 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $655,618 | 126,812 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $783,698 | 126,812 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $478,081 | 126,812 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $392,399 | 143,736 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $217,666 | 18,944 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $333,807 | 17,937 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $416,682 | 18,511 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $489,426 | 17,580 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $286,267 | 11,437 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $237,879 | 7,869 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||